Henry Schein welcomes three new members to the executive management committee. The new members include Steve Boggan, Bianka ...

UK #2024 #insights #zenopa #recruitment #Vaccination #key #BEST #protection #strangles #animal #health #healthcare ...

GSK has reported positive outcomes from a late-stage study on gepotidacin, an oral treatment for urogenital gonorrhoea in ...

UK #2024 #insights #zenopa #recruitment #Shimadzu #Scientific #Instruments #Launches #US #Facility #Research #Development ...

UK #2024 #insights #zenopa #recruitment #Shimadzu #Scientific #Instruments #Launches #US #Facility #Research #Development ...

Wayne Kemp has been appointed as CASCO’s group managing director, a new position that showcases the organisation’s ongoing ...

Lonza and NeuroSense Therapeutics have collaborated to identify exosome-derived biomarkers to expedite the diagnosis and ...

The organisation seeks to progress technologies for managing cancer. This includes creating tools to reduce inaccurate tissue ...

Abbvie’s migraine treatment has received a final draft guidance from the National Institute for Health and Care Excellence for NHS use in over 18-year-olds. The treatment ‘Aquipta’ can be used for the ...

Paroxysmal nocturnal hemoglobinuria is a rare, acquired disorder characterised by the abnormal breakdown of red blood cells, leading to symptoms such as hemolytic anaemia, thrombosis, and bone marrow ...

LCW Medical Communications Client Service Officer, Kelly Farley, and CEO, Lucy Williams, have unveiled the procurement of Mediconf UK. LCW Medical Communications is a company that specialises in ...

ELIAS Cancer Immunotherapy is set to be the only adoptive cell treatment for canine osteosarcoma, a type of bone cancer in dogs. The corporation is seeking a $10m in an early-stage financing round to ...